Clinical implications of technological advances in screening for atrial fibrillation

The incidence of atrial fibrillation (AF) continues to increase worldwide as people live longer. AF is the leading cause of stroke among patients older than 75  years and is responsible for at least 15% of all strokes. Industry has responded to this problem with a plethora of monitoring devices. These include single lead ECG adhesive sensors, implantable loop recorders, smartphone attachments and wearables. This review will concentrate on clinical studie s using these technologies. There are wearables including watches and watch-like devices that will be mentioned but these have not been validated for clinical use.
Source: Progress in Cardiovascular Diseases - Category: Cardiology Authors: Source Type: research